GlassScriptPhysician profile
Timothy C Benning
NPI 1053393199
$2,454.64
in general payments reported to CMS, 2019-2025
10 companies · $1,447 in 2025
The $1,447 reported for 2025 was more than what a typical Vascular & Interventional Radiology provider received nationally (typical 2025 total: $537).
See the full distribution for Vascular & Interventional Radiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $469 · 2022: $132 · 2023: $121 · 2024: $287 · 2025: $1,447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,018 · Travel and Lodging: $836.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,018.41 |
| Travel and Lodging | $835.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $1,255.60 | 2025 | Indigo System, Penumbra System |
| Inari Medical, INC. | $407.63 | 2019-2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Stryker Corporation | $239.34 | 2019 | |
| Philips North America LLC | $201.92 | 2019-2023 | |
| Shockwave Medical, INC | $105.60 | 2025 | |
| Terumo Medical Corporation | $105.41 | 2024 | Azur Cx Detachable |
| Globus Medical, INC. | $85.41 | 2025 | Senza |
| Angiodynamics, INC. | $19.04 | 2022 | |
| Astellas Pharma US INC | $17.40 | 2019 | |
| Boston Scientific Corporation | $17.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Benning listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.